Postma Robert W 4
4 · Alaunos Therapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
Postma Robert W
Director
Transactions
- Purchase
Series A-1 Convertible Preferred Stock
2025-04-11$2.76/sh+500$1,380→ 500 total(indirect: By WaterMill Asset Management Corp.)Exercise: $2.76From: 2025-04-11→ Common Stock (181,159 underlying) - Award
Common Stock
2025-04-13$2.92/sh+20,804$60,748→ 29,083 total - Purchase
Series A-2 Convertible Preferred Stock
2025-06-24$4.49/sh+600$2,694→ 600 total(indirect: By Watermill Asset Management Corp)Exercise: $4.49From: 2025-06-24→ Common Stock (133,630.29 underlying)
Holdings
- 33,333(indirect: By WaterMill Asset Management Corp.)
Common Stock
- 24(indirect: By Spouse)
Common Stock
- 3,737
Employee Stock Option (right to buy)
Exercise: $10.30Exp: 2034-06-05→ Common Stock (3,737 underlying)
Footnotes (4)
- [F1]The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
- [F2]The preferred stock is perpetual and therefore has no expiration date.
- [F3]The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance.
- [F4]One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon.